This study is looking at lung disease in people who have recently been diagnosed with rheumatoid arthritis (RA). Researchers want to understand how common lung problems are in early RA and what they look like. They will use lung scans (High Resolution Computed Tomography Chest Scan), breathing tests, questionnaires, and blood tests to gather this information. The study also aims to find new markers in the blood, like anti-malondialdehyde-acetaldehyde (MAA) antibodies, that might predict who will develop lung disease. You may be able to join if you are 19-90 years old and have been diagnosed with RA within the past two years. The study status is currently unclear.

Study design

This is an observational study, meaning researchers will gather information without giving any specific treatments. It plans to include 125 participants.

What's involved

You would undergo a High Resolution Computed Tomography (CT) Chest Scan at your first visit, along with pulmonary function tests, questionnaires, and serum (blood) studies. The duration of participation is not specified.

Compensation

Not stated in the trial record.

Follow-up

Your High Resolution Computed Tomography Chest Scan results will be measured at Baseline (Visit 1 only). The record mentions a goal to follow newly diagnosed RA patients long-term through electronic medical record surveys and biobank samples, but specific follow-up duration for participants is not detailed.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.